{"id":157168,"date":"2026-07-16T10:52:29","date_gmt":"2026-07-16T10:52:29","guid":{"rendered":"https:\/\/pabau.com\/?p=157168"},"modified":"2026-08-17T12:10:10","modified_gmt":"2026-08-17T12:10:10","slug":"icd-10-code-c413","status":"publish","type":"post","link":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/","title":{"rendered":"ICD-10 Code C41.3: Malignant neoplasm of ribs, sternum and clavicle"},"content":{"rendered":"\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"MedicalWebPage\",\"headline\":\"ICD-10 Code C41.3: Malignant neoplasm of ribs, sternum and clavicle\",\"description\":\"ICD-10 Code C41.3 (Malignant neoplasm of ribs, sternum and clavicle) is a billable primary bone malignancy code. Learn applicable sites, excludes notes, MS-DRG mapping, and documentation requirements.\",\"url\":\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c413\/\",\"audience\":{\"@type\":\"MedicalAudience\",\"audienceType\":\"Clinician\"},\"reviewedBy\":{\"@type\":\"Person\",\"name\":\"Dr Vanja Kitanova\",\"jobTitle\":\"Medical Reviewer\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"Pabau\"},\"knowsAbout\":[\"Medical Coding\",\"Clinical Documentation\",\"Healthcare Billing\",\"Clinical Safety\"],\"sameAs\":\"https:\/\/pabau.com\/blog\/author\/vanja\/\"},\"datePublished\":\"2026-07-16\",\"dateModified\":\"2026-07-16\"}<\/script>\n\n\n        <div id=\"key_takeaways\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/12\/Key-Takeaways-Icon.svg\" alt=\"Key Takeaways\" height=\"42\" width=\"42\">\n                                <h3>Key Takeaways<\/h3>\n            <\/div>\n            <div class=\"list\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>ICD-10 Code C41.3 describes malignant neoplasm of ribs, sternum and clavicle, a billable primary bone cancer code effective October 1, 2025.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>C41.3 applies to costal cartilage, costovertebral joint, and xiphoid process in addition to the named bones.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>C41.3 codes primary bone malignancy only; metastatic bone disease uses C79.51, and confusing them causes claim denials and audit flags.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Pabau&rsquo;s claims management software helps oncology and orthopedic practices apply C41.3 accurately and reduce coding errors at the point of documentation.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<p class=\"wp-block-paragraph\">Most bone malignancy coding errors happen before the claim ever reaches the payer. A coder selects C41.3 for a patient with metastatic lung cancer that has spread to the ribs, the claim denies, and the audit trail reveals the wrong primary designation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>ICD-10 Code C41.3<\/strong> is the correct code only when the ribs, sternum, or clavicle are the site of origin, not a metastatic target. The 2026 ICD-10-CM edition of this code became effective on October 1, 2025, and applies across oncology, orthopedic surgery, and inpatient reimbursement contexts.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This reference covers the applicable anatomical sites, excludes restrictions, MS-DRG mapping, and documentation requirements coders need to apply C41.3 correctly.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"ICD-10 Revisions: Stay Updated or Fall Behind\" width=\"800\" height=\"450\" src=\"https:\/\/www.youtube.com\/embed\/bqAyb-BCA0w?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">According to the <a href=\"https:\/\/icd.who.int\/browse10\/2019\/en\" target=\"_blank\" rel=\"nofollow noopener\">WHO ICD-10 browser<\/a>, C41.3 sits within the C40-C41 block for malignant neoplasms of bone and articular cartilage, specifically the \u00ab\u00a0other and unspecified sites\u00a0\u00bb category under C41. The US Clinical Modification version used under HIPAA-compliant clinical records adds site-specific detail through the ICD-10-CM tabular list.<\/p>\n\n\n\n<h2 id=\"h-icd-10-code-c41-3-definition-and-billable-status\" class=\"wp-block-heading\">ICD-10 Code C41.3: definition and billable status<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">C41.3 is a billable, specific ICD-10-CM code valid for reimbursement purposes in the 2026 edition. It describes a malignant neoplasm arising primarily in the ribs, sternum, or clavicle, including the associated cartilaginous and joint structures of the thoracic cage.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C41.3<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Full description<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of ribs, sternum and clavicle<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Billable\/specific<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code system<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ICD-10-CM (US Clinical Modification)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Effective date<\/td>\n<td style=\"padding:12px 16px;color:#374151\">October 1, 2025 (FY2026 edition)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Parent block<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C40-C41: Malignant neoplasms of bone and articular cartilage<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Malignancy type<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Primary bone malignancy only<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The code applies to primary malignancies documented as originating in the thoracic cage structures. Coders using dermatology EMR software for oncology-adjacent skin and soft-tissue cases should verify that the operative or pathology report identifies the listed structure as the primary site before selecting this code.<\/p>\n\n\n\n<h2 id=\"h-applicable-anatomical-sites-covered-by-c41-3\" class=\"wp-block-heading\">Applicable anatomical sites covered by C41.3<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The ICD-10-CM tabular list extends C41.3 beyond the named bones to include adjacent structures under \u00ab\u00a0Applicable To\u00a0\u00bb inclusions. Coders unfamiliar with these inclusions often query unnecessary codes for the same anatomical region.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Ribs<\/strong>: all ribs (true, false, floating)<\/li>\n\n\n\n<li><strong>Sternum<\/strong>: the breastbone including the manubrium and body<\/li>\n\n\n\n<li><strong>Clavicle<\/strong>: the collarbone<\/li>\n\n\n\n<li><strong>Costal cartilage<\/strong>: the cartilage connecting ribs to the sternum<\/li>\n\n\n\n<li><strong>Costovertebral joint<\/strong>: the joint between a rib and its corresponding vertebra<\/li>\n\n\n\n<li><strong>Xiphoid process<\/strong>: the inferior projection of the sternum<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">All six structures above use C41.3 as the single billable code when the malignancy is primary. No additional specificity code exists within ICD-10-CM for laterality of ribs, so the coder documents the site detail in the medical record without appending a laterality modifier to the code itself.<\/p>\n\n\n\n<h2 id=\"h-excludes-notes-for-icd-10-code-c41-3\" class=\"wp-block-heading\">Excludes notes for ICD-10 Code C41.3<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The C41 category carries a single set of exclusion notes that restrict how C41.3 interacts with other codes. Getting these wrong can trigger a claim edit or an Excludes1 compliance flag during audit.<\/p>\n\n\n\n<h3 id=\"h-excludes1-hard-exclusion\" class=\"wp-block-heading\">Excludes1 (hard exclusion)<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">An Excludes1 note means the excluded code and C41.3 can never be reported together for the same patient encounter. Category C41 carries an Excludes1 note directing six related presentations to other codes instead:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Malignant neoplasm of bones of limbs (C40.-)<\/li>\n\n\n\n<li>Malignant neoplasm of cartilage of the ear (<a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c490\/\">C49.0<\/a>)<\/li>\n\n\n\n<li>Malignant neoplasm of cartilage of the eyelid (C49.0)<\/li>\n\n\n\n<li>Malignant neoplasm of cartilage of the larynx (C32.3)<\/li>\n\n\n\n<li>Malignant neoplasm of cartilage of the limbs (C40.-)<\/li>\n\n\n\n<li>Malignant neoplasm of cartilage of the nose (C30.0)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">A chondrosarcoma documented as arising in nasal cartilage, for example, is never coded to C41.3 \u2014 it belongs under C30.0.<\/p>\n\n\n\n<h3 id=\"h-no-excludes2-note-for-c41\" class=\"wp-block-heading\">No Excludes2 note for C41<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Category C41 does not carry an Excludes2 note. That means combinations like C41.3 with C79.51 (secondary malignant neoplasm of bone) are governed by clinical documentation and the primary-versus-secondary distinction covered earlier in this article, not by a formal excludes instruction.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A patient with a primary rib tumor (C41.3) who also has bone metastases from another site can still be coded with both C41.3 and C79.51 when the documentation supports both diagnoses \u2014 there is simply no excludes note dictating that combination either way.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Check the pathology report before selecting C41.3. A report reading &lsquo;malignant cells in bone&rsquo; without identifying the primary site is not sufficient documentation for C41.3. The clinician must specify that the rib, sternum, or clavicle is the primary tumor site.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-c41-3-within-the-c40-c41-bone-malignancy-code-block\" class=\"wp-block-heading\">C41.3 within the C40-C41 bone malignancy code block<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">C41.3 is one of five site-specific codes under C41. Understanding the sibling codes helps coders confirm they have the right code and not a near-miss neighbor. The same logic governs musculoskeletal codes elsewhere in ICD-10-CM .<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Notes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C41.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of bones of skull and face<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Excludes mandible (C41.1)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C41.1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of mandible<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Lower jaw bone only<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C41.2<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of vertebral column<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Excludes sacrum and coccyx (C41.4)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\"><strong>C41.3<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#374151\"><strong>Malignant neoplasm of ribs, sternum and clavicle<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#374151\"><strong>Includes costal cartilage, costovertebral joint, xiphoid process<\/strong><\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C41.4<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of pelvic bones, sacrum and coccyx<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Includes hip bone, pubic bone, ischium<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C41.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of bone and articular cartilage, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Non-specific; use only when site cannot be determined<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">C41.2 is the most common near-miss for C41.3. When a thoracic tumor involves the vertebral body adjacent to a rib, the coder must determine from the pathology report or operative note whether the primary site is the vertebra (C41.2) or the costovertebral joint (included under C41.3).<\/p>\n\n\n\n<h2 id=\"h-primary-vs-secondary-bone-malignancy-choosing-the-right-code\" class=\"wp-block-heading\">Primary vs secondary bone malignancy: choosing the right code<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The single most consequential coding decision for bone malignancy is distinguishing primary from secondary disease. This distinction affects DRG assignment, reimbursement level, and cancer registry reporting. The oncology chapter applies the same requirement elsewhere.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Scenario<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Correct code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Rationale<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Osteosarcoma arising in the rib (no prior malignancy)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C41.3<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Primary bone malignancy; rib is the site of origin<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Chondrosarcoma of the sternum<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C41.3<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Primary malignancy of sternum; included under C41.3<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Lung cancer with rib metastasis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C79.51 + C34.xx<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Secondary malignant neoplasm of bone; primary is the lung<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Breast cancer with sternal metastasis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C79.51 + C50.xx<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Secondary malignant neoplasm of bone; primary is the breast<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Primary site unknown, malignant cells found in rib on biopsy<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C80.1 (primary unknown) or C79.51<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Do not assign C41.3 without documented primary site confirmation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The ICD-10-CM Official Guidelines for Coding and Reporting state that when a malignancy is described as metastatic \u00ab\u00a0to\u00a0\u00bb a site, that site is the secondary location. When described as arising \u00ab\u00a0in\u00a0\u00bb or \u00ab\u00a0of\u00a0\u00bb a site, that site is primary. The word choice in the physician&rsquo;s documentation drives the code assignment.<\/p>\n\n\n\n<h2 id=\"h-ms-drg-mapping-for-c41-3\" class=\"wp-block-heading\">MS-DRG mapping for C41.3<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">For inpatient reimbursement, C41.3 maps to MS-DRG groupings under the CMS IPPS grouper. Verify specific DRG values against the current CMS IPPS grouper for the applicable fiscal year, as values update annually with each CMS rule. The <a href=\"https:\/\/www.cms.gov\/medicare\/coding-billing\/icd-10-codes\" target=\"_blank\" rel=\"nofollow noopener\">CMS ICD-10-CM coding resources<\/a> page publishes annual grouper files.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">MS-DRG<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">MCC\/CC requirement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">542<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Pathological fractures and musculoskeletal and connective tissue malignancy with MCC<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Major complication\/comorbidity required<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">543<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Pathological fractures and musculoskeletal and connective tissue malignancy with CC<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Complication\/comorbidity required<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">544<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Pathological fractures and musculoskeletal and connective tissue malignancy without CC\/MCC<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No additional requirement<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The presence or absence of a major complication or comorbidity (MCC\/CC) in the inpatient record directly determines which DRG tier C41.3 maps to. Incomplete comorbidity documentation reduces reimbursement to the lower-weight DRG. Coders should query the attending physician when comorbidities appear in nursing or ancillary notes but are absent from the physician&rsquo;s documented problem list.<\/p>\n\n\n        <div id=\"book_a_demo\">\n            <div class=\"left-side\">\n                <div class=\"logo\">\n                    <img decoding=\"async\"\n                        src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Logo.svg\"\n                        alt=\"Logo\"\n                        loading=\"lazy\"\n                    \/>\n                <\/div>\n\n                <h3 class=\"heading\">\n                    Reduce coding errors and claim denials                <\/h3>\n\n                <p class=\"description\">\n                    Pabau&rsquo;s clinical documentation and claims management tools help oncology and orthopedic practices apply ICD-10 codes accurately from the point of care.                <\/p>\n\n                <div class=\"button-group\">\n                    <a href=\"\/book-demo\/\" class=\"btn btn-scale-effect btn-cta-color btn-md\">\n                        <span class=\"btn-text\">Book a demo<\/span>\n                        <div class=\"btn-icon btn-icon-right\" aria-hidden=\"true\">\n                            <svg\n                                width=\"14\"\n                                height=\"12\"\n                                viewBox=\"0 0 14 12\"\n                                fill=\"none\"\n                                xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                            >\n                                <path\n                                    d=\"M0.75 4.77295C0.335786 4.77295 0 5.10874 0 5.52295C0 5.93716 0.335786 6.27295 0.75 6.27295V5.52295V4.77295ZM13.2803 6.05328C13.5732 5.76039 13.5732 5.28551 13.2803 4.99262L8.50736 0.219648C8.21447 -0.073245 7.73959 -0.073245 7.4467 0.219648C7.15381 0.512542 7.15381 0.987415 7.4467 1.28031L11.6893 5.52295L7.4467 9.76559C7.15381 10.0585 7.15381 10.5334 7.4467 10.8263C7.73959 11.1191 8.21447 11.1191 8.50736 10.8263L13.2803 6.05328ZM0.75 5.52295V6.27295L12.75 6.27295V5.52295V4.77295L0.75 4.77295V5.52295Z\"\n                                    fill=\"currentColor\"\n                                ><\/path>\n                            <\/svg>\n                        <\/div>\n                    <\/a>\n                <\/div>\n            <\/div>\n\n            <div class=\"right-side\">\n                <img decoding=\"async\"\n                    src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Home-Page-Concept-4.webp\"\n                    alt=\"Pabau clinical documentation and claims management dashboard\"\n                    loading=\"lazy\"\n                \/>\n            <\/div>\n        <\/div>\n        \n\n\n<h2 id=\"h-documentation-requirements-for-bone-cancer-coding\" class=\"wp-block-heading\">Documentation requirements for bone cancer coding<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Accurate use of C41.3 depends on what the clinician documents, not on what the coder infers. Missing documentation elements are the root cause of most bone malignancy claim denials. Using structured medical documentation processes reduces the likelihood of submitting a code the clinical note cannot support.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Primary site:<\/strong> the operative report, pathology report, or physician note must state that the rib, sternum, clavicle, or an included structure (costal cartilage, costovertebral joint, xiphoid process) is the site of origin<\/li>\n\n\n\n<li><strong>Histologic type:<\/strong> document the tumor histology where available (osteosarcoma, chondrosarcoma, Ewing sarcoma); this supports medical necessity and cancer registry reporting<\/li>\n\n\n\n<li><strong>Primary vs metastatic status:<\/strong> the note must clearly indicate whether the malignancy is primary or metastatic; vague language such as \u00ab\u00a0bone lesion\u00a0\u00bb or \u00ab\u00a0malignant cells in bone\u00a0\u00bb is insufficient<\/li>\n\n\n\n<li><strong>Staging information:<\/strong> document TNM staging or equivalent when available; while not required for code assignment, it supports medical necessity review<\/li>\n\n\n\n<li><strong>Comorbidities:<\/strong> document all active comorbidities explicitly in the physician note to support MCC\/CC assignment for DRG optimization<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Practices using clinical documentation software make it easier for physicians to record primary-site specificity at the point of care. Coders may not infer a primary site from imaging alone without physician confirmation.<\/p>\n\n\n\n<h2 id=\"h-common-coding-errors-and-how-to-avoid-them\" class=\"wp-block-heading\">Common coding errors and how to avoid them<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Three patterns account for the majority of C41.3 coding errors in inpatient and outpatient claims. Addressing these at the point of documentation prevents denial cycles that take weeks to resolve. A billing compliance checklist built into the clinical workflow catches most of these before submission.<\/p>\n\n\n\n<h3 id=\"h-error-1-assigning-c41-3-to-metastatic-bone-disease\" class=\"wp-block-heading\">Error 1: assigning C41.3 to metastatic bone disease<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">This is the most common error. A patient with known breast cancer develops rib pain. Imaging shows a lytic rib lesion. The coder assigns C41.3 without checking whether the lesion is a metastasis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The correct code is C79.51 (secondary malignant neoplasm of bone and bone marrow) plus the breast cancer code. C41.3 is reserved for tumors where the rib, sternum, or clavicle is documented as the site of origin.<\/p>\n\n\n\n<h3 id=\"h-error-2-assigning-c41-3-to-malignancies-the-excludes1-note-routes-elsewhere\" class=\"wp-block-heading\">Error 2: assigning C41.3 to malignancies the Excludes1 note routes elsewhere<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The Excludes1 note above routes several related tumors away from C41.3, including malignant neoplasms of the limb bones and of cartilage in the ear, eyelid, larynx, and nose.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">When documentation places the tumor in one of these structures, C41.3 is never the correct code, even if the site sits close to the thoracic cage. A sarcoma documented as arising in the cartilage of the larynx, for instance, is coded to C32.3, not C41.3.<\/p>\n\n\n\n<h3 id=\"h-error-3-selecting-c41-2-instead-of-c41-3-for-costovertebral-joint-tumors\" class=\"wp-block-heading\">Error 3: selecting C41.2 instead of C41.3 for costovertebral joint tumors<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The costovertebral joint is included under C41.3, not C41.2 (vertebral column). When a tumor is documented as involving the costovertebral joint, select C41.3. If the tumor extends from the vertebral body into the joint, a clinical query to the attending physician clarifies the primary site and prevents an incorrect C41.2 assignment.<\/p>\n\n\n\n<h2 id=\"h-icd-9-cm-to-icd-10-cm-crosswalk-for-c41-3\" class=\"wp-block-heading\">ICD-9-CM to ICD-10-CM crosswalk for C41.3<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Practices migrating historical records or reconciling older claims against current coding need the ICD-9 equivalent. The General Equivalence Mappings (GEMs) published by CMS provide the forward and backward mappings. Confirm against the <a href=\"https:\/\/icd10cmtool.cdc.gov\/\" target=\"_blank\" rel=\"nofollow noopener\">CDC\/NCHS ICD-10-CM lookup tool<\/a> for the most current mapping table.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-9-CM code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-9 description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-10-CM equivalent<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">170.3<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of ribs, sternum, and clavicle<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C41.3<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The mapping from ICD-9-CM 170.3 to ICD-10-CM C41.3 is a one-to-one forward conversion. Practices that transitioned from ICD-9 to ICD-10 in October 2015 and retained legacy records coded under 170.3 can map those encounters directly to C41.3 for historical reporting purposes.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>When auditing legacy claims from before October 2015, verify that ICD-9 code 170.3 was the code in use and not a secondary bone metastasis code. The conversion is valid only for primary rib, sternum, and clavicle malignancies coded before the ICD-10 transition.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">Related ICD-10 codes<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c61\/\">ICD-10 code for prostate cancer \u2014 C61<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c494\/\">ICD-10 code C49.4 \u2014 Malignant neoplasm of connective and soft tissue<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c496\/\">ICD-10 C49.6 \u2014 Malignant soft tissue neoplasm of the trunk<\/a><\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-how-pabau-supports-accurate-icd-10-cm-c41-3-coding\" class=\"wp-block-heading\">How Pabau supports accurate ICD-10-CM C41.3 coding<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Oncology, orthopedic. The distance between what the clinician documents and what the coder sees on screen is where primary-vs-secondary errors occur most often.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau&rsquo;s claims management software brings the clinical note and the billing code into a single workflow. Coders can review structured documentation alongside the code assignment without toggling between systems, which reduces the errors that creep in when notes are transcribed hours or days after the encounter.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The platform&rsquo;s AI-assisted clinical documentation tools help clinicians capture primary site specificity, histology, and comorbidity documentation during the encounter, not as an afterthought.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For practices managing patient data security alongside billing compliance, Pabau&rsquo;s <a href=\"https:\/\/pabau.com\/features\/medical-records-management\/\">clinical documentation tools<\/a> maintain a complete, timestamped audit trail for each encounter, supporting both payer audit responses and cancer registry submission workflows.<\/p>\n\n\n\n<h2 id=\"h-conclusion\" class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">C41.3 coding errors consistently trace back to the same root cause: a clinician note that says \u00ab\u00a0malignancy in the rib\u00a0\u00bb without confirming whether that rib is the primary tumor site or a metastatic target. Resolving that ambiguity at the point of care, before the claim is submitted, is the most effective denial-prevention step available to coders.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau&rsquo;s integrated clinical documentation and claims management keeps the physician note and code assignment in the same workflow, preventing the documentation-to-billing mismatches where most C41.3 errors originate. To see how Pabau handles this for oncology and orthopedic practices, <a href=\"https:\/\/pabau.com\/book-demo\/\">book a demo<\/a>.<\/p>\n\n\n        <div id=\"expert_picks\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/11\/Expert-Picks.svg\" alt=\"Continue your research\" height=\"42\" width=\"42\">\n                                <h3>Continue your research<\/h3>\n            <\/div>\n            <div class=\"content\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Coding a rib or extremity fracture instead of a malignancy?<\/strong> <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-s8261xn\/\" rel=\"noopener\">S82.61XN<\/a> walks through a musculoskeletal fracture coding scenario.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need the procedure-side counterpart for a chest wall excision?<\/strong> Review procedure code <a href=\"https:\/\/pabau.com\/procedure-codes\/cpt-code-11644\/\" rel=\"noopener\">11644<\/a> for malignant lesion excision billing.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Handling a musculoskeletal neck diagnosis in the same encounter?<\/strong> <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-m436\/\" rel=\"noopener\">M43.6<\/a> covers torticollis coding requirements.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Documenting a related joint condition?<\/strong> <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-m660\/\" rel=\"noopener\">M66.0<\/a> addresses popliteal cyst rupture coding.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Coding a craniofacial or skeletal deformity note?<\/strong> <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-m952\/\" rel=\"noopener\">M95.2<\/a> covers acquired head deformity classification.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-frequently-asked-questions\" class=\"wp-block-heading\">Frequently Asked Questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1784190239317\"><h3 class=\"schema-faq-question\">What does ICD-10 Code C41.3 mean?<\/h3> <p class=\"schema-faq-answer\">ICD-10 Code C41.3 is a billable ICD-10-CM diagnosis code for malignant neoplasm of ribs, sternum, and clavicle. It covers primary bone malignancies arising in these thoracic cage structures and also includes costal cartilage, costovertebral joint, and xiphoid process under its Applicable To inclusions.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784190239318\"><h3 class=\"schema-faq-question\">Is C41.3 a billable ICD-10-CM code?<\/h3> <p class=\"schema-faq-answer\">Yes. C41.3 is a billable, specific ICD-10-CM code valid for reimbursement purposes in the 2026 FY edition, which became effective October 1, 2025. It can be used as a primary diagnosis on claims submitted to Medicare, Medicaid, and commercial payers.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784190239319\"><h3 class=\"schema-faq-question\">What is the difference between C41.3 and secondary malignant neoplasm of bone?<\/h3> <p class=\"schema-faq-answer\">C41.3 is used only when the ribs, sternum, or clavicle are the site of origin of the cancer. Secondary malignant neoplasm of bone (C79.51) is used when cancer from another primary site, such as lung or breast, has metastasized to the bone. Using C41.3 for metastatic disease is a coding error that triggers claim denials and compliance flags.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784190239320\"><h3 class=\"schema-faq-question\">What are the excludes notes for C41.3?<\/h3> <p class=\"schema-faq-answer\">Category C41 carries a single Excludes1 note, directing malignant neoplasm of bones of limbs (C40.-) and malignant neoplasm of cartilage of the ear (C49.0), eyelid (C49.0), larynx (C32.3), and nose (C30.0) to those codes instead, meaning none of them can be reported together with C41.3. C41 does not carry an Excludes2 note.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784190239321\"><h3 class=\"schema-faq-question\">What documentation is required to use C41.3?<\/h3> <p class=\"schema-faq-answer\">The clinician must document that the rib, sternum, clavicle, or an included structure is the primary tumor site. Supporting documentation should include histologic type where available, primary versus metastatic status, staging information, and any comorbidities that affect DRG assignment. Imaging findings alone are not sufficient; physician confirmation of the primary site is required per ICD-10-CM guidelines.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784190239322\"><h3 class=\"schema-faq-question\">What is the ICD-9-CM equivalent of C41.3?<\/h3> <p class=\"schema-faq-answer\">The ICD-9-CM equivalent is code 170.3 (malignant neoplasm of ribs, sternum, and clavicle). The mapping from 170.3 to C41.3 is a direct one-to-one forward conversion under the CMS General Equivalence Mappings (GEMs). Verify current mappings against the CDC\/NCHS ICD-10-CM lookup tool.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Most bone malignancy coding errors happen before the claim ever reaches the payer. A coder selects C41.3 for a patient with metastatic lung cancer that has spread to the ribs, the claim denies, and the audit trail reveals the wrong primary designation. ICD-10 Code C41.3 is the correct code only when the ribs, sternum, or [&hellip;]<\/p>\n","protected":false},"author":77,"featured_media":157167,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_linkdex":"81","_yoast_wpseo_content_score":"30","_yoast_wpseo_is_cornerstone":"","_yoast_wpseo_keywordsynonyms":"[\"\",\"\",\"\",\"\"]","_yoast_wpseo_focuskw_text_input":"","_seo_original_html":"","footnotes":""},"categories":[1549,1550],"tags":[2675,1513,3741],"class_list":["post-157168","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-diagnostic-codes","category-icd-10-cm","tag-billable-code","tag-malignant-neoplasm-icd-10","tag-oncology-coding"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ICD-10 Code C41.3: Billable Rib and Clavicle Cancer<\/title>\n<meta name=\"description\" content=\"C41.3 is billable for FY2026, covering primary rib, sternum, and clavicle tumors. Metastatic bone disease uses C79.51 instead.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICD-10 Code C41.3: Billable Rib and Clavicle Cancer\" \/>\n<meta property=\"og:description\" content=\"C41.3 is billable for FY2026, covering primary rib, sternum, and clavicle tumors. Metastatic bone disease uses C79.51 instead.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/\" \/>\n<meta property=\"og:site_name\" content=\"Pabau\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pabau\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-16T10:52:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-17T12:10:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c413.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Katy Piper\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:site\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Katy Piper\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/\"},\"author\":{\"name\":\"Katy Piper\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/person\\\/5de22f4ff3ec59b1925ef02dce956d7d\"},\"headline\":\"ICD-10 Code C41.3: Malignant neoplasm of ribs, sternum and clavicle\",\"datePublished\":\"2026-07-16T10:52:29+00:00\",\"dateModified\":\"2026-08-17T12:10:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/\"},\"wordCount\":2367,\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c413.webp\",\"keywords\":[\"Billable code\",\"malignant neoplasm icd 10\",\"Oncology Coding\"],\"articleSection\":[\"Diagnostic Codes\",\"ICD-10-CM\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/\",\"name\":\"ICD-10 Code C41.3: Billable Rib and Clavicle Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c413.webp\",\"datePublished\":\"2026-07-16T10:52:29+00:00\",\"dateModified\":\"2026-08-17T12:10:10+00:00\",\"description\":\"C41.3 is billable for FY2026, covering primary rib, sternum, and clavicle tumors. Metastatic bone disease uses C79.51 instead.\",\"mainEntity\":[{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239317\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239318\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239319\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239320\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239321\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239322\"}],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c413.webp\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c413.webp\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/\",\"name\":\"Pabau\",\"description\":\"Clinic Software for your Business | Go Paperless Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pabau.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\",\"name\":\"Pabau\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"width\":736,\"height\":195,\"caption\":\"Pabau\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Pabau\\\/\",\"https:\\\/\\\/x.com\\\/pabaucrm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pabau-ltd\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pabausoftware\\\/\"],\"description\":\"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.\",\"foundingDate\":\"2011-10-20\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/person\\\/5de22f4ff3ec59b1925ef02dce956d7d\",\"name\":\"Katy Piper\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"caption\":\"Katy Piper\"},\"description\":\"Katy Piper is a content writer covering aesthetics, dermatology, and clinic operations, with a knack for making clinical detail feel approachable. Outside of work, she's usually chasing her border collie around muddy fields or hunting down the best flat white in town.\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/blog\\\/author\\\/katy-piper\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239317\",\"position\":1,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239317\",\"name\":\"What does ICD-10 Code C41.3 mean?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ICD-10 Code C41.3 is a billable ICD-10-CM diagnosis code for malignant neoplasm of ribs, sternum, and clavicle. It covers primary bone malignancies arising in these thoracic cage structures and also includes costal cartilage, costovertebral joint, and xiphoid process under its Applicable To inclusions.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239318\",\"position\":2,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239318\",\"name\":\"Is C41.3 a billable ICD-10-CM code?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. C41.3 is a billable, specific ICD-10-CM code valid for reimbursement purposes in the 2026 FY edition, which became effective October 1, 2025. It can be used as a primary diagnosis on claims submitted to Medicare, Medicaid, and commercial payers.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239319\",\"position\":3,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239319\",\"name\":\"What is the difference between C41.3 and secondary malignant neoplasm of bone?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"C41.3 is used only when the ribs, sternum, or clavicle are the site of origin of the cancer. Secondary malignant neoplasm of bone (C79.51) is used when cancer from another primary site, such as lung or breast, has metastasized to the bone. Using C41.3 for metastatic disease is a coding error that triggers claim denials and compliance flags.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239320\",\"position\":4,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239320\",\"name\":\"What are the excludes notes for C41.3?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Category C41 carries a single Excludes1 note, directing malignant neoplasm of bones of limbs (C40.-) and malignant neoplasm of cartilage of the ear (C49.0), eyelid (C49.0), larynx (C32.3), and nose (C30.0) to those codes instead, meaning none of them can be reported together with C41.3. C41 does not carry an Excludes2 note.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239321\",\"position\":5,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239321\",\"name\":\"What documentation is required to use C41.3?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The clinician must document that the rib, sternum, clavicle, or an included structure is the primary tumor site. Supporting documentation should include histologic type where available, primary versus metastatic status, staging information, and any comorbidities that affect DRG assignment. Imaging findings alone are not sufficient; physician confirmation of the primary site is required per ICD-10-CM guidelines.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239322\",\"position\":6,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c413\\\/#faq-question-1784190239322\",\"name\":\"What is the ICD-9-CM equivalent of C41.3?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The ICD-9-CM equivalent is code 170.3 (malignant neoplasm of ribs, sternum, and clavicle). The mapping from 170.3 to C41.3 is a direct one-to-one forward conversion under the CMS General Equivalence Mappings (GEMs). Verify current mappings against the CDC\\\/NCHS ICD-10-CM lookup tool.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ICD-10 Code C41.3: Billable Rib and Clavicle Cancer","description":"C41.3 is billable for FY2026, covering primary rib, sternum, and clavicle tumors. Metastatic bone disease uses C79.51 instead.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/","og_locale":"fr_FR","og_type":"article","og_title":"ICD-10 Code C41.3: Billable Rib and Clavicle Cancer","og_description":"C41.3 is billable for FY2026, covering primary rib, sternum, and clavicle tumors. Metastatic bone disease uses C79.51 instead.","og_url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/","og_site_name":"Pabau","article_publisher":"https:\/\/www.facebook.com\/Pabau\/","article_published_time":"2026-07-16T10:52:29+00:00","article_modified_time":"2026-08-17T12:10:10+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c413.webp","type":"image\/webp"}],"author":"Katy Piper","twitter_card":"summary_large_image","twitter_creator":"@pabaucrm","twitter_site":"@pabaucrm","twitter_misc":{"\u00c9crit par":"Katy Piper","Dur\u00e9e de lecture estim\u00e9e":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#article","isPartOf":{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/"},"author":{"name":"Katy Piper","@id":"https:\/\/pabau.com\/fr\/#\/schema\/person\/5de22f4ff3ec59b1925ef02dce956d7d"},"headline":"ICD-10 Code C41.3: Malignant neoplasm of ribs, sternum and clavicle","datePublished":"2026-07-16T10:52:29+00:00","dateModified":"2026-08-17T12:10:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/"},"wordCount":2367,"publisher":{"@id":"https:\/\/pabau.com\/fr\/#organization"},"image":{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c413.webp","keywords":["Billable code","malignant neoplasm icd 10","Oncology Coding"],"articleSection":["Diagnostic Codes","ICD-10-CM"],"inLanguage":"fr-FR"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/","url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/","name":"ICD-10 Code C41.3: Billable Rib and Clavicle Cancer","isPartOf":{"@id":"https:\/\/pabau.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#primaryimage"},"image":{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c413.webp","datePublished":"2026-07-16T10:52:29+00:00","dateModified":"2026-08-17T12:10:10+00:00","description":"C41.3 is billable for FY2026, covering primary rib, sternum, and clavicle tumors. Metastatic bone disease uses C79.51 instead.","mainEntity":[{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239317"},{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239318"},{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239319"},{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239320"},{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239321"},{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239322"}],"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#primaryimage","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c413.webp","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c413.webp","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/pabau.com\/fr\/#website","url":"https:\/\/pabau.com\/fr\/","name":"Pabau","description":"Clinic Software for your Business | Go Paperless Today","publisher":{"@id":"https:\/\/pabau.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pabau.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/pabau.com\/fr\/#organization","name":"Pabau","url":"https:\/\/pabau.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","width":736,"height":195,"caption":"Pabau"},"image":{"@id":"https:\/\/pabau.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pabau\/","https:\/\/x.com\/pabaucrm","https:\/\/www.linkedin.com\/company\/pabau-ltd\/","https:\/\/www.instagram.com\/pabausoftware\/"],"description":"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.","foundingDate":"2011-10-20","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/pabau.com\/fr\/#\/schema\/person\/5de22f4ff3ec59b1925ef02dce956d7d","name":"Katy Piper","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","caption":"Katy Piper"},"description":"Katy Piper is a content writer covering aesthetics, dermatology, and clinic operations, with a knack for making clinical detail feel approachable. Outside of work, she's usually chasing her border collie around muddy fields or hunting down the best flat white in town.","url":"https:\/\/pabau.com\/fr\/blog\/author\/katy-piper\/"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239317","position":1,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239317","name":"What does ICD-10 Code C41.3 mean?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"ICD-10 Code C41.3 is a billable ICD-10-CM diagnosis code for malignant neoplasm of ribs, sternum, and clavicle. It covers primary bone malignancies arising in these thoracic cage structures and also includes costal cartilage, costovertebral joint, and xiphoid process under its Applicable To inclusions.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239318","position":2,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239318","name":"Is C41.3 a billable ICD-10-CM code?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Yes. C41.3 is a billable, specific ICD-10-CM code valid for reimbursement purposes in the 2026 FY edition, which became effective October 1, 2025. It can be used as a primary diagnosis on claims submitted to Medicare, Medicaid, and commercial payers.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239319","position":3,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239319","name":"What is the difference between C41.3 and secondary malignant neoplasm of bone?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"C41.3 is used only when the ribs, sternum, or clavicle are the site of origin of the cancer. Secondary malignant neoplasm of bone (C79.51) is used when cancer from another primary site, such as lung or breast, has metastasized to the bone. Using C41.3 for metastatic disease is a coding error that triggers claim denials and compliance flags.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239320","position":4,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239320","name":"What are the excludes notes for C41.3?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Category C41 carries a single Excludes1 note, directing malignant neoplasm of bones of limbs (C40.-) and malignant neoplasm of cartilage of the ear (C49.0), eyelid (C49.0), larynx (C32.3), and nose (C30.0) to those codes instead, meaning none of them can be reported together with C41.3. C41 does not carry an Excludes2 note.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239321","position":5,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239321","name":"What documentation is required to use C41.3?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The clinician must document that the rib, sternum, clavicle, or an included structure is the primary tumor site. Supporting documentation should include histologic type where available, primary versus metastatic status, staging information, and any comorbidities that affect DRG assignment. Imaging findings alone are not sufficient; physician confirmation of the primary site is required per ICD-10-CM guidelines.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239322","position":6,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c413\/#faq-question-1784190239322","name":"What is the ICD-9-CM equivalent of C41.3?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The ICD-9-CM equivalent is code 170.3 (malignant neoplasm of ribs, sternum, and clavicle). The mapping from 170.3 to C41.3 is a direct one-to-one forward conversion under the CMS General Equivalence Mappings (GEMs). Verify current mappings against the CDC\/NCHS ICD-10-CM lookup tool.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"}]}},"yoast":{"focus_keyword":"ICD-10 Code C41.3","seo_title":"ICD-10 Code C41.3: Billable Rib and Clavicle Cancer","meta_description":"C41.3 is billable for FY2026, covering primary rib, sternum, and clavicle tumors. Metastatic bone disease uses C79.51 instead.","content_score":"30","is_cornerstone":"","related_keyphrases":[{"keyword":"malignant neoplasm of ribs sternum clavicle","score":65},{"keyword":"C41.3 billable code","score":61},{"keyword":"primary bone malignancy coding","score":67}]},"_links":{"self":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/157168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/users\/77"}],"replies":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/comments?post=157168"}],"version-history":[{"count":4,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/157168\/revisions"}],"predecessor-version":[{"id":182832,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/157168\/revisions\/182832"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/media\/157167"}],"wp:attachment":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/media?parent=157168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/categories?post=157168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/tags?post=157168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}